N1c colon cancer and the use of adjuvant chemotherapy: a current audit of the National Cancer Database-Reference-Cited by-同舟云学术

N1c colon cancer and the use of adjuvant chemotherapy: a current audit of the National Cancer Database

Published:2020-11-24 Issue:3 Volume:23 Page:653-663
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorectal Dis

Author:

Simon Hillary L.¹,Reif de Paula Thais¹^ORCID,Spigel Zachary A.²^ORCID,Keller Deborah S.³^ORCID

Affiliation:

1. Division of Colorectal Surgery Department of Surgery Columbia University Medical Center New York New York USA

2. Department of Surgery Allegheny General Hospital Pittsburgh Pennsylvania USA

3. Division of Colorectal Surgery Department of Surgery Herbert Irving Comprehensive Cancer Center Columbia University Medical Center New York New York USA

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/codi.15406

Reference59 articles.

1. AJCC 8th Edition: Colorectal Cancer

2. The Prognostic Significance of Extramural Deposits and Extracapsular Lymph Node Invasion in Colon Cancer

3. BensonAB VenookAP Al‐HawaryMM ArainMA ChenYJ CiomborKK et al.NCCN guidelines version 2.2020 colon cancer NCCN evidence blocks TM Continue NCCN guidelines panel disclosures.2020.www.nccn.org/patients. Accessed 23 Mar 2020

4. Is the Seventh Edition of the UICC/AJCC TNM Staging System Reasonable for Patients With Tumor Deposits in Colorectal Cancer?

5. Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour deposits in colon cancer predict recurrence and reduced survival in a nationwide population-based study;BJS Open;2023-11-01

2. Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients;World Journal of Gastroenterology;2023-03-21

3. A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification;Cancer Treatment Reviews;2022-02